USP10 and cardiac hypertrophy: These studies provided compelling evidence confirming the role of USP10 in cardiac hypertrophy, and indicated that USP10 inhibition exacerbated pressure overload-induced cardiac dysfunction and facilitated angiotensin II-induced cardiomyocyte injury.